Ls Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Ls Investment Advisors, LLC

$656 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $1.16 Million - $1.36 Million	-6,169 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $145,949 - $170,123	-705 Reduced 10.26%	6,169 $1.33 Million
Q4 2020 Feb 10, 2021	SELL	$207.01 - $276.09 $3,519 - $4,693	-17 Reduced 0.25%	6,874 $1.63 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $5,879 - $6,971	23 Added 0.33%	6,891 $1.88 Million
Q2 2020 Aug 10, 2020	SELL	$225.48 - $295.8 $55,919 - $73,358	-248 Reduced 3.49%	6,868 $1.99 Million
Q1 2020 Apr 20, 2020	SELL	$199.77 - $247.81 $107,076 - $132,826	-536 Reduced 7.0%	7,116 $1.69 Million
Q4 2019 Jan 31, 2020	SELL	$166.71 - $223.91 $40,510 - $54,410	-243 Reduced 3.08%	7,652 $1.68 Million
Q3 2019 Oct 31, 2019	BUY	$166.23 - $187.09 $12,965 - $14,593	78 Added 1.0%	7,895 $1.34 Million
Q2 2019 Aug 07, 2019	SELL	$164.61 - $190.37 $16,625 - $19,227	-101 Reduced 1.28%	7,817 $1.43 Million
Q1 2019 Apr 25, 2019	BUY	$163.73 - $194.7 $47,317 - $56,268	289 Added 3.79%	7,918 $1.46 Million
Q4 2018 Feb 01, 2019	SELL	$151.91 - $192.21 $24,457 - $30,945	-161 Reduced 2.07%	7,629 $1.26 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $70,782 - $81,336	-422 Reduced 5.14%	7,790 $1.5 Million
Q2 2018 Jul 20, 2018	BUY	$145.72 - $169.96 $9,034 - $10,537	62 Added 0.76%	8,212 $1.4 Million
Q1 2018 May 08, 2018	SELL	$151.6 - $177.13 $65,036 - $75,988	-429 Reduced 5.0%	8,150 $1.33 Million
Q4 2017 Feb 07, 2018	BUY	$137.28 - $155.55 $230,493 - $261,168	1,679 Added 24.33%	8,579 $1.29 Million
Q3 2017 Oct 19, 2017	BUY	$148.13 - $162.24 $1.02 Million - $1.12 Million	6,900	6,900 $1.05 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.

Account